| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.004 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.006 |